Zobrazeno 1 - 7
of 7
pro vyhledávání: '"59"'
Autor:
Peter J. Frederick, J. Brian Szender, Kunle Odunsi, K.S. Grzankowski, Shashikant Lele, Chandra L. Spring-Robinson
Publikováno v:
International Journal of Gynecologic Cancer. 26:1440-1447
BackgroundThe time interval between diagnoses of breast cancer (BC) and endometrial cancer (EC) is not well established in women with metachronous primary tumors. We sought to examine this interval and identify associations with treatment-related and
Autor:
Josephine S. Kim, Kristine R. Penner, Chi E Wang, Rebecca A. Brooks, Jean A. Hurteau, Margaret I. Liang, Jill Alldredge, Tilley Jenkins Vogel, Carolyn V. Kirschner, Joshua G. Cohen, Avisek Datta, Ilana Cass, Gustavo C. Rodriguez, E.N. Prendergast, E.D. Moore
Publikováno v:
Int J Gynecol Cancer
ObjectivesTo compare clinical outcomes for stage IIIC and IV ovarian cancer patients receiving neoadjuvant chemotherapy and interval cytoreductive surgery followed by up to three versus more cycles of post-operative chemotherapy.MethodsWe conducted a
Autor:
Vincent C.C. Cheng, Tiffany H Y Leung, Sally C. Y. Wong, Rosana W.S. Poon, CP Wong, Chuen-Hing Foo, Vivian C M Lam, Jonathan H. K. Chen, Kwok-Yung Yuen, Antonio H. Y. Ngan, Herman Tse
Publikováno v:
Journal of Clinical Pathology. 71:781-786
AimsGranulomatous mastitis due toCorynebacterium kroppenstedtiiis an increasingly recognised cause of an indolent and distressing mastitis in non-lactating females. This slow-growing lipophilic organism is not reliably isolated using routine culture
Autor:
Andrew Furness, Paul Nathan, Shanthini M Crusz, Jessica Little, Camellia Richards, Bhavisha Sheth, Nikki Hunter, James Larkin, Kathleen Mchugh, Julia Choy, Sophie Papa, Samra Turajlic, David J. Pinato, Muhammad Saheb Khan, Julian Teare, Lisa Pickering, Nick Powell, Ally Speight, Anand Sharma, Raguprakash Ratnakumaran, Dharmisha Chauhan, James L. Alexander, Hajir Ibraheim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
IntroductionImmune checkpoint inhibitors (CPIs) have changed the treatment landscape for many cancers, but also cause severe inflammatory side effects including enterocolitis. CPI-induced enterocolitis is treated empirically with corticosteroids, and
Autor:
Sonia Van Dooren, Hendrik Everaert, Julia Katharina Schwarze, Mark M. Kockx, Isabelle Salmon, Laura Seynaeve, Cleo Bertels, Samuel Klein, Gil Awada, Ramses Forsyth, Anne-Marie Vanbinst, Johnny Duerinck, Nicky D'Haene, Jens Tijtgat, Wietse Geens, Ben Caljon, Bart Neyns, Louise Cras, Alex Michotte, Freya Vaeyens, Michaël Bruneau
Publikováno v:
Journal for ImmunoTherapy of Cancer, 9 (6
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Patients with recurrent glioblastoma (rGB) have a poor prognosis with a median overall survival (OS) of 30-39 weeks in prospective clinical trials. Intravenous administration of programmed cell death protein 1 and cytotoxic T-lymphocyte-as
Autor:
S.M. Kim, S.J. Lee, T.S. Kwon, Seung-Cheol Shim, Chang-Hee Suh, S.Y. Lee, D.-H. Yoo, Won Park
Publikováno v:
Annals of the Rheumatic Diseases. 75:241.2-242
Background A randomised controlled trial (RCT) and its open label extension trial (OLE) demonstrated comparable pharmacokinetics (PK), efficacy and safety between CT-P10 and innovator rituximab (RTX) (including switched from RTX to CT-P10) up to 2 ye
Autor:
Michael McCarthy
Publikováno v:
BMJ. :i2061
The US Preventive Services Task Force has recommended low dose aspirin for the primary prevention of cardiovascular disease and colorectal cancer in adults aged 50 to 59 years who are at high risk of cardiovascular disease. The recommendations apply